Drug intelligence / Profile preview

Pavirona

Development stage
Preclinical
Lead developer
Mealis
Modality
Small Molecules
Administration
Oral
01

Overview

**Pavirona** is an oral multi-ingredient nutraceutical tablet marketed for supportive management of cervical human papillomavirus infection. The product is described as containing quercetin, green tea extract, cinnamon extract, selenium, and licorice root extract, and is presented in the cited clinical literature as a fixed-composition phytochemical formulation intended to support HPV DNA clearance and cytologic regression during routine follow-up rather than replace standard gynecologic management. Its putative mechanism is multi-factorial and indirect, combining antiviral, antioxidant, immunomodulatory, and epithelial-recovery effects attributed to its constituent ingredients; preclinical rationale cited for the formulation includes suppression of HPV-related oncogenic signaling, modulation of oxidative stress pathways, and enhancement of host immune surveillance. The excerpt identifies the product as Papivir/Pavirona from Mealis and notes that the same ingredient composition has also been described under the separate product names Gene-Eden-VIR and Novirin.

Brand names
PavironaPapivir

Beyond the preview

Go deeper on Pavirona.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pavirona.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call